Antioxidant Status of Patients on Peritoneal Dialysis: Associations with Inflammation and Glycoxidative Stress

Boeschoten E.W. , Scrijver J. , Krediet R.T. , Schreurs W.H.P. , Arisz L. Deficiencies of vitamins in CAPD patients: the effect of supplementation. Nephrol Dial Transplant 1988; 2: 87–93.

Blumberg A. , Hanck A. , Sander G. Vitamin nutrition in patients on continuous ambulatory peritoneal dialysis (CAPD). Clin Nephrol 1983; 20: 244–50.

Ozden M. , Maral H. , Akaydin D. , Cetinalp P. , Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem 2002; 35: 269–73.

Tarng D.C. , Chen T.W. , Huang T.P. , Chen C.L. , Liu T.Y. , Wei Y.H. Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol 2002; 13: 1321–30.

Bonnefont-Rousselot D. , Jaudon M.C. , Issad B. , Cacoub P. , Congy F. , Jardel C. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1997; 12: 1399–405.

Handelman G.J. Evaluation of oxidant stress in dialysis patients. Blood Purif 2000; 18: 343–9.

Miyata T. , Ueda Y. , Horie K. , Nangaku M. , Tanaka S. , van Ypersele de Strihou C. Renal catabolism of advanced glycation end products: the fate of pentosidine. Kidney Int 1998; 53: 416–22.

Miyata T. , Horie K. , Ueda Y. , Fujita Y. , Izuhara Y. , Hirano H. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int 2000; 58: 425–35.

Qureshi A.R. , Alvestrand A. , Divino-Filho J.C. , Gutierrez A. , Heimburger O. , Lindholm B. Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 2002; 13(Suppl 1): S28–36.

Zimmermann J. , Herrlinger S. , Pruy A. , Metzger T. , Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648–58.

Suliman M.E. , Heimburger O. , Barany P. , Anderstam B. , Pecoits-Filho R. , Rodriguez Ayala E. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol 2003; 14: 1614–22.

Schwedler S.B. , Metzger T. , Schinzel R. , Wanner C. Advanced glycation end products and mortality in hemodialysis patients. Kidney Int 2002; 62: 301–10.

Gokal R. , Mallick N.P. Peritoneal dialysis. Lancet 1999; 353: 823–8.

Maiorca R. , Sandrini S. , Cancarini G.C. , Gaggia P. , Chiappini R. , Setti G. Integration of peritoneal dialysis and transplantation programs. Perit Dial Int 1997; 17(Suppl 2): S170–4.

McGregor S.J. , Topley N. , Jorres A. , Speekenbrink A.B. , Gordon A. , Gahl G.M. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism. Kidney Int 1996; 49: 525–33.

Li F.K. , Davenport A. , Robson R.L. , Loetscher P. , Rothlein R. , Williams J.D. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 1998; 54: 2170–83.

Topley N. Membrane longevity in peritoneal dialysis: impact of infection and bio-incompatible solutions. Adv Ren Replace Ther 1998; 5: 179–84.

Witowski J. , Jorres A. , Korybalska K. , Ksiazek K. , Wisniewska-Elnur J. , Bender T.O. Glucose degradation products in peritoneal dialysis fluids: do they harm? Kidney Int Suppl 2003; 84: S148–51.

Miyata T. , Devuyst O. , Kurokawa K. , van Ypersele de Strihou C. Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes. Kidney Int 2002; 61: 375–86.

Erixon M. , Wieslander A. , Lindén T. , Carlsson O. , Forsbäck G. , Svensson E. How to avoid glucose degradation products in peritoneal dialysis fluids. Perit Dial Int 2006; 26: 490–7.

Singh R. , Barden A. , Mori T. , Beilin L. Advanced glycation end-products: a review. Diabetologia 2001; 44: 129–46.

Roob J.M. , Rabold T. , Hayn M. , Khoschsorur G. , Resch U. , Holzer H. Ex vivo low-density lipoprotein oxidizability and in vivo lipid peroxidation in patients on CAPD. Kidney Int Suppl 2001; 78: S128–36.

Janero D.R. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. Free Radic Biol Med 1990; 9: 515–40.

Schmidt A.M. , Yan S.D. , Wautier J.L. , Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999; 84: 489–97.

Bierhaus A. , Hofmann M.A. , Ziegler R. , Nawroth P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998; 37: 586–600.

Schwedler S. , Schinzel R. , Vaith P. , Wanner C. Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship? Kidney Int Suppl 2001; 78: S32–6.

Chew B.P. , Park J.S. Carotenoid action on the immune response. J Nutr 2004; 134: 257S–61S.

Krinsky N.I. Actions of carotenoids in biological systems. Ann Rev Nutr 1993; 13: 561–87.

Hughes D.A. Effects of carotenoids on human immune function. Proc Nutr Soc 1999; 58: 713–18.

Levine M. , Wang Y. , Rumsey S.C. Analysis of ascorbic acid and dehydroascorbic acid in biological samples. Methods Enzymol 1999; 299: 65–76.

Lykkesfeldt J. , Loft S. , Poulsen H.E. Determination of ascorbic acid and dehydroascorbic acid in plasma by high-performance liquid chromatography with coulometric detection—are they reliable markers of oxidative stress? Anal Biochem 1995; 299: 329–35.

Aebischer C.P. , Schierle J. , Schüep W. Simultaneous determination of retinol, tocopherols, carotene, lycopene, and xanthophylls in plasma by means of reversed-phase high performance liquid chromatography. Methods Enzymol 1999; 299: 348–62.

Khoschsorur G.A. , Winklhofer–Roob B.M. , Rabl H. , Auer T. , Peng Z. , Schaur R.J. Evaluation of a sensitive HPLC method for the determination of malondialdehyde, and application of the method to different biological materials. Chromatographia 2000; 52: 181–4.

Takahashi M. , Kushida K. , Kawana K. , Ishihara C. , Denda M. , Inoue T. Quantification of the cross-link pentosidine in serum from normal and uremic subjects. Clin Chem 1993; 39: 2162–5.

Winklhofer–Roob B.M. , Puhl H. , Khoschsorur G. , van't Hof M.A. , Esterbauer H. , Shmerling D.H. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis. Free Radic Biol Med 1995; 18: 849–59.

Food and Nutrition Board. Vitamin C. In: Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. Washington, DC: National Academy Press; 2000: 95–185.

Sullivan J.F. , Eisenstein A.B. , Mottola O.M. , Mittal A.K. The effect of dialysis on plasma and tissue levels of vitamin C. Trans Am Soc Artif Intern Organs 1972; 18: 277–82.

Shah G.M. , Ross E.A. , Sabo A. , Pichon M. , Bhagavan H. , Reynolds R.D. Ascorbic acid supplements in patients receiving chronic peritoneal dialysis. Am J Kidney Dis 1991; 18: 84–90.

Shah G.M. , Ross E.A. , Sabo A. , Pichon M. , Reynolds R.D. , Bhagavan H. Effects of ascorbic acid and pyridoxine supplementation on oxalate metabolism in peritoneal dialysis patients. Am J Kidney Dis 1992; 20: 42–9.

Mydlik M. , Derzsiova K. , Svac J. , Dlhopolcek P. , Zemberova E. Peritoneal clearance and peritoneal transfer of oxalic acid, vitamin C, and vitamin B6 during continuous ambulatory peritoneal dialysis. Artif Organs 1998; 22: 784–8.

Grandhee S.K. , Monnier V.M. Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors. J Biol Chem 1991; 266: 11649–53.

Slight S.H. , Feather M.S. , Ortwerth B.J. Glycation of lens proteins by the oxidative products of ascorbic acid. Biochem Biophys Acta 1990; 1038: 367–74.

Ortwerth B.J. , Olesen P.R. Glutathione inhibits the glycation and crosslinking of lens proteins by ascorbic acid. Exp Eye Res 1988; 47: 737–50.

Weiss M.F. , Erhard P. , Kader-Attia F.A. , Wu Y.C. , Deoreo P.B. , Araki A. Mechanisms for the formation of glycoxidation products in end-stage renal disease. Kidney Int 2000; 57: 2571–85.

Takahashi M. , Oikawa M. , Nagano A. Effect of age and menopause on serum concentrations of pentosidine, an advanced glycation end product. J Gerontol A Biol Sci Med Sci 2000; 55: 137–40.

Sugiyama S. , Miyata T. , Ueda Y. , Tanaka H. , Maeda K. , Kawashima S. Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol 1998; 9: 1681–8.

Bayazit A.K. , Vogt B.A. , Dell K.M. , Davis I.D. , Noyan A. , Anarat A. Effect of peritoneal dialysis prescription on pentosidine in children. Pediatr Nephrol 2003; 18: 1049–54.

Makita Z. , Radoff S. , Rayfield E.J. , Yang Z. , Skolnik E. , Delaney V. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 325: 836–42.

Li P.K. , Cheng Y.L. Therapeutic options for preservation of residual renal function in patients on peritoneal dialysis. Perit Dial Int 2007; 27(Suppl 2): S158–63.

Ha T.K. , Sattar N. , Talwar D. , Cooney J. , Simpson K. , O'Reilly D.S. Abnormal antioxidant vitamin and carotenoid status in chronic renal failure. QJM 1996; 89: 765–9.

Kanai M. , Raz A. , Goodman D.S. Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 1968; 47: 2025–44.

Mogielnicki R.P. , Waldmann T.A. , Strober W. Renal handling of low molecular weight proteins. I. L-Chain metabolism in experimental renal disease. J Clin Invest 1971; 50: 901–9.

Rosales F.J. , Ross A.C. Acute inflammation induces hyporetinemia and modifies the plasma and tissue response to vitamin A supplementation in marginally vitamin Adeficient rats. J Nutr 1998; 128: 960–6.

Walston J. , Xue Q. , Semba R.D. , Ferrucci L. , Cappola A.R. , Ricks M. Serum antioxidants, inflammation, and total mortality in older women. Am J Epidemiol 2006; 163: 18–26.

Watzl B. , Kulling S.E. , Moseneder J. , Barth S.W. , Bub A. A 4-wk intervention with high intake of carotenoid-rich vegetables and fruit reduces plasma C-reactive protein in healthy, nonsmoking men. Am J Clin Nutr 2005; 82: 1052–8.

Kimmel P.L. , Phillips T.M. , Simmens S.J. , Peterson R.A. , Weihs K.L. , Alleyne S. Immunologic function and survival in hemodialysis patients. Kidney Int 1998; 54: 236–44.

Yeum K.J. , Booth S.L. , Sadowski J.A. , Liu C. , Tang G. , Krinsky N.I. Human plasma carotenoid response to the ingestion of controlled diets high in fruits and vegetables. Am J Clin Nutr 1996; 64: 594–602.

Nikolakakis N. , Kounali D. , Tornaritis M. , Anastassou A. , Papadakis E. , Kassotakis G. Adipose tissue fatty acid composition, serum lipids, and serum α–tocopherol in continuous ambulatory peritoneal dialysis patients living on the island of Crete. Perit Dial Int 1999; 19: 154–9.

Food and Nutrition Board. Vitamin E. In: Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. Washington, DC: National Academy Press; 2000: 186–283.

Mydlik M. , Derzsiova K. , Racz O. , Sipulova A. , Boldizsar J. , Lovasova E. Vitamin E as an antioxidant agent in CAPD patients. Int J Artif Organs 2002; 25: 373–8.

Roob J.M. , Khoschsorur G. , Tiran A. , Horina J.H. , Holzer H. , Winklhofer–Roob B.M. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol 2000; 11: 539–49.

Daschner M. , Lenhartz H. , Botticher D. , Schaefer F. , Wollschlager M. , Mehls O. Influence of dialysis on plasma lipid peroxidation products and antioxidant levels. Kidney Int 1996; 50: 1268–72.